Accepted for/Published in: JMIR Medical Informatics
Date Submitted: Mar 19, 2025
Date Accepted: Aug 28, 2025
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Hypertension Medication Recommendation via Synergistic and Selective Modeling of Heterogeneous Medical Entities: A Study
ABSTRACT
Background:
Electronic health records (EHR) store rich data involving medical entities such as diagnoses, treatment procedures, and prescribed medications, offering valuable resources for developing automated systems for hypertension medication recom-mendations. The entities in EHR show significant synergies during treatment. How-ever, existing medication recommendation methods mainly focus on homogeneous graphs, overlooking the crucial synergistic relationships among heterogeneous medical entities. Also, accurately modeling the progression of hypertension using EHR is essential for precise medication recommendations, but current approaches often lack comprehensive temporal modeling and don't fully meet clinical require-ments.
Objective:
To overcome the challenges in existing methods, introduce a novel model for hy-pertension medication recommendation that leverages the synergy and selectivity of heterogeneous medical entities.
Methods:
First, use patient EHR to construct both heterogeneous and homogeneous graphs. Then, capture the inter-entity synergies with a multi-head graph attention mecha-nism to enhance entity-level representations. Next, apply a dual-layer temporal se-lection mechanism to calculate selective coefficients between current and historical visit records and aggregate them to form refined visit-level representations. Finally, determine medication recommendation probabilities based on these comprehen-sive patient representations.
Results:
Experimental evaluations on the real-world dataset MIMIC-IV v2.2 show that the model achieves a Jaccard similarity coefficient of 55.82%, a precision-recall AUC of 80.69%, and an F1 score of 64.83%, outperforming baseline models.
Conclusions:
The findings indicate the superior efficacy of the introduced model in medication recommendation, highlighting its potential to enhance clinical decision-making in the management of hypertension.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.